| __timestamp | Merus N.V. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 3852327 | 6795238 |
| Thursday, January 1, 2015 | 839656 | 7454247 |
| Friday, January 1, 2016 | 4478145 | 10345862 |
| Sunday, January 1, 2017 | 16432324 | 16984203 |
| Monday, January 1, 2018 | 11890871 | 16187290 |
| Tuesday, January 1, 2019 | 34110000 | 9299233.54 |
| Wednesday, January 1, 2020 | 35781000 | 19232000 |
| Friday, January 1, 2021 | 40896000 | 23611000 |
| Saturday, January 1, 2022 | 52200000 | 26700000 |
| Sunday, January 1, 2023 | 59836000 | 28215000 |
Cracking the code
In the competitive world of biotechnology, understanding financial trends is crucial. Over the past decade, Summit Therapeutics Inc. and Merus N.V. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Merus N.V. experienced a staggering 1,450% increase in SG&A expenses, peaking in 2023. In contrast, Summit Therapeutics Inc. saw a more modest 315% rise over the same period.
Merus N.V.'s expenses surged significantly post-2018, reflecting strategic investments or expansions. Meanwhile, Summit Therapeutics Inc. maintained a steadier growth, with a notable spike in 2020. This divergence highlights differing operational strategies and market responses. Investors and stakeholders should consider these trends when evaluating company performance and future potential.
SG&A Efficiency Analysis: Comparing Pfizer Inc. and Summit Therapeutics Inc.
Selling, General, and Administrative Costs: Incyte Corporation vs Summit Therapeutics Inc.
Summit Therapeutics Inc. or Catalent, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Sarepta Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Summit Therapeutics Inc. and Lantheus Holdings, Inc.
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Ionis Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs Perrigo Company plc
Operational Costs Compared: SG&A Analysis of Summit Therapeutics Inc. and Protagonist Therapeutics, Inc.
Summit Therapeutics Inc. or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs Galapagos NV
Selling, General, and Administrative Costs: ADMA Biologics, Inc. vs Merus N.V.
Breaking Down SG&A Expenses: ACADIA Pharmaceuticals Inc. vs Merus N.V.